Nature Reviews Urology

Papers
(The median citation count of Nature Reviews Urology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Sexual recovery interventions following prostate cancer treatment179
Novel intravesical gemcitabine delivery system (TAR-200) for neoadjuvant treatment of MIBC: context is everything160
Texture analysis for patient selection138
Single-cell and spatial sequencing of kidney cancer115
Exploratory results from the CheckMate 214 trial95
Human-relevant urothelial model provides insight into infection strategies and host response75
Krause corpuscles act as genital vibration detectors64
Immune infiltration associated with outcomes63
Semen quality recovery following COVID-1962
PARP inhibitors plus enzalutamide to treat mCRPC62
Time for women-centred gynaecology61
Top, bottom or vers? Creating a more equitable health system for sexual and gender minority patients with prostate cancer60
Urine microbiota differ in bladder cancer60
Advancing the state of the art in congenital obstructive uropathy56
High-dose chemotherapy for relapsed testicular germ cell tumours56
Considering urology in a planetary context55
Preclinical models of bladder cancer: BBN and beyond54
Implementation of patient-reported outcome measures into health care for men with localized prostate cancer50
Proteomic-based analysis of testicular interstitial fluid49
A clinical guide to rare male sexual disorders49
FOXA2–KIT-driven lineage plasticity in NEPC49
Prevalence of gender dysphoria in Japan48
A new text message-based platform for self-management of patients with IC/BPS47
The evolving landscape of monogenic nephrolithiasis and therapeutic innovations45
Overcoming antibiotic resistance in complicated UTI45
Promise without practice — charting the path forward for bladder cancer biomarkers43
Madrid plays host to a celebration of urology42
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers41
Microfluidic sperm selection41
What happens in Vegas … shapes the future of urology41
Galectins as potential therapeutic targets in STIs in the female genital tract39
Reducing the stigma of academic mental health can save lives39
Is SARS-CoV-2-induced testicular damage in hamsters relevant?39
Metaverse in surgery — origins and future potential37
Antibiotic therapy for treating overactive bladder is not supported by clinical evidence36
Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer36
Evolution of the World Health Organization semen analysis manual: where are we?36
Bioinformatics in urology — molecular characterization of pathophysiology and response to treatment34
A non-invasive assay for UTUC diagnosis34
Pembrolizumab + axitinib beyond first-line therapy for mRCC34
Vaccination to prevent untreatable gonorrhoea34
Resolving the puzzle of same-sex sexual interactions34
COVID can’t kill CopMich collaboration34
Quest for a genetic biomarker for sickle cell disease priapism: rationale, progress and implications33
Pain management in percutaneous nephrolithotomy — an approach rooted in pathophysiology33
Personalized 3D models for prostate cancer surgery32
Efficacy of the Revi system in treating urgency urinary incontinence32
PEACEing together prostate cancer therapy31
The mechanism of action of neuromodulation in the treatment of overactive bladder30
Author Correction: Can PROMs improve racial equity in outcomes after prostatectomy?30
Measuring and improving the cradle-to-grave environmental performance of urological procedures30
Sexual orientation, gender identity and COVID: a complicated picture30
Quality checkpoints in the MRI-directed prostate cancer diagnostic pathway30
Is it time to rethink the current patient-reported outcome measures?28
Rucaparib improves PFS in patients with BRCA1/2-altered mCRPC27
Effect of high glucose on E. coli27
Cribriform morphology affects mpMRI imaging26
Secondary kidney stones — remove or leave?26
The magic of MagSToNE26
A distinct TAM subset mediates immunotherapy resistance in prostate cancer25
Women in urology: the past25
Microultrasonography-guided prostate cancer biopsy24
AUA returns to its former glory in Chicago24
Promising efficacy of UTI vaccines as an alternative to antibiotics24
Successful mentorship for women in urology — a new era24
Robots learning to imitate surgeons — challenges and possibilities23
Prostate cancer in transgender women — challenges in research and clinical care23
Videourodynamics — role, benefits and optimal practice23
Excluding PLND in favourable intermediate-risk prostate cancer: a PSMA-PET-directed perspective22
The placebo and nocebo effects in functional urology22
Current and emerging strategies to curb antibiotic-resistant urinary tract infections22
Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer21
Centralization of care for rare genetic syndromes associated with cancer: improving outcomes and advancing research on VHL disease20
Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwards20
A clinical overview of people living with HIV and genitourinary cancer care18
Metabolic response to immunotherapy in prostate cancer17
Androgen receptor pathway inhibitor combination in prostate cancer17
Going in circles: circMGA–HNRNPL feedback loop in bladder cancer17
Detecting lymph node metastases for personalized radiotherapy in patients with prostate cancer16
Management and cost of stent encrustation in pregnancy16
Immune-based therapies in penile cancer15
Evolving language reflects evolving understanding: updated terms for anatomical description in i/VSC/DSD15
Turning up the heat: CTLA4 blockade in urothelial cancer15
Pride, not prejudice15
AI for antibiotic design15
Overall survival with adjuvant pembrolizumab in renal cell carcinoma — the shock of the lightning15
Recurrence mechanisms of non-muscle-invasive bladder cancer — a clinical perspective14
De-clear cell differentiated renal cell carcinoma — a new therapeutic target13
The future of patient-derived xenografts in prostate cancer research13
The prognostic role of stroma in UTUC13
The evolving treatment landscape of metastatic urothelial cancer13
Uncovering a link between COVID-19 and renal cell carcinoma12
Improved phenotypic classification of male infertility to promote discovery of genetic causes12
The value of women urologists — individual and institutional imperatives to address salary equity12
Turning back time in the testes12
We all get erections — de-gendering sexual arousal dysfunction in the ICD12
Current and future pharmacotherapy for female sexual dysfunction11
Vitamins as regulators of calcium-containing kidney stones — new perspectives on the role of the gut microbiome11
Pelvic-fascia-sparing techniques and outcomes with RARP11
The shifting treatment paradigm of metastatic renal cell carcinoma11
New evidence and novel techniques for assessing intraoperative margins during radical prostatectomy11
Breaking the silence: normalizing receptive anal intercourse for patients, for people and for myself11
Power up to investigate PrEP10
CMA mediates resistance to androgen inhibitors in prostate cancer10
Effects of COVID-19 vaccine on semen parameters10
Patient selection is key in IMbassador25010
Hallmark discoveries in the biology of Wilms tumour10
Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer10
Tuft cells in prostate cancer10
Men hold the balance of power10
BAUSing back in Birmingham10
The unclear role of PET–CT in localized radiorecurrent prostate cancer10
Metabolism, mitochondria and metastasis in kidney cancer9
Diagnosis of ccRCC9
Mellow yellow: BilR reduces bilirubin to urobilinogen9
ARNEO: neoadjuvant degarelix + apalutamide before surgery for high-risk prostate cancer9
Spatiotemporal trends in human semen quality8
Microbiota manipulation to prevent oxalate kidney stone formation8
Male infertility and somatic health — insights into lipid damage as a mechanistic link8
Mechanisms of the intestinal and urinary microbiome in kidney stone disease8
A prompt-based stewardship to reduce extended-spectrum antibiotic treatment in UTI8
Mechanisms of the Supra-T paradox7
The ins and outs of penile erection7
Testosterone replacement therapy and spermatogenesis in reproductive age men7
Stepping up to prevent bacterial vaginosis recurrence7
MRI diagnosis and radical prostatectomy outcomes7
Pronouns in English: a user’s guide7
Chlorination by-products in drinking water — association with bladder cancer risk7
Pathophysiology and potential multimodal therapeutic strategies for IC/BPS7
Genetic ancestry and racial differences in prostate tumours7
Semen parameters across testicular cancer stages7
Advances in sliding clip renorrhaphy for partial nephrectomy7
Sperm activity affected by endometriosis6
A great gathering at the 4th Clinical and Scientific Advances in UTI conference6
Urology on a changing planet: links between climate change and urological disease6
Artificial intelligence in the management of prostate cancer6
Visual clues — dermatological manifestations of sexually transmitted infections in men6
Prostate luminal progenitor cells: from mouse to human, from health to disease6
Von Hippel–Lindau protein signalling in clear cell renal cell carcinoma6
Feasibility and potential of an MRI-based prostate cancer screening6
Genetic and biological drivers of prostate cancer disparities in Black men6
Toilet-based continuous health monitoring using urine6
Particulate matter leaves a bitter taste in testes6
Syphilis on the rise — a need for alternative therapies and vaccines6
Influence of substance use on male reproductive health and offspring outcomes6
Clinical trial design for non-muscle-invasive bladder cancer6
Improving care for transgender and non-binary individuals5
The effects of diet on prostate cancer outcomes5
Prescribing clinician specialty influences adherence to PrEP5
Mutagenic effect of chemotherapy on sperm DNA and implications for family planning5
Iatrogenic upper urinary tract injuries during ureteroscopy for urolithiasis: a comprehensive review on incidence, mechanisms and preventative strategies5
An app for optimizing UTI screening5
Reply to ‘Management of very young fetuses with LUTO’5
The future of pelvic lymph node dissection for urological malignancies5
Pregnancy and parental leave in medicine and academia — a focus on urology5
Exploring the impact of lipid stress on sperm cytoskeleton: insights and prospects5
Gut microbiome’s effect on immunotherapy response5
Bone marrow microenvironment in prostate cancer5
GDF15 blockade can reduce immunotherapy resistance in urothelial cancer5
The prostatic middle lobe: clinical significance, presentation and management5
ADT intensification to treat biochemically recurrent prostate cancer5
Being a non-native English speaker in science and medicine5
Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma5
New insights into APOBEC-mediated mutagenesis in prostate cancer5
Sexual transfer of bacteria for forensic use5
The effect of red blood cell disorders on male fertility and reproductive health4
PIONEER big data platform for prostate cancer: lessons for advancing future real-world evidence research4
Non-human primates as a translational model for the study of male reproductive health4
A vagina on a chip to model microbiome–host interactions4
Advancing perioperative care in MIBC: insights from NIAGARA4
A urologist as a urological patient4
Landmarks in the evolution of prostate biopsy4
Managing autonomic dysreflexia during urological care in individuals living with spinal cord injury4
Metastasis development in non-muscle-invasive bladder cancer4
Patient-reported outcomes in metastatic renal cell carcinoma trials using combinations versus sunitinib as first-line treatment4
CRISPR–Cas9 potential for identifying novel therapeutic targets in muscle-invasive bladder cancer4
Clinical hypnosis improves LUTS3
Can systematic biopsy be omitted from the prostate cancer diagnostic pathway?3
The testosterone paradox of advanced prostate cancer: mechanistic insights and clinical implications3
Prostate cancer epigenetics — from pathophysiology to clinical application3
A new surgical procedure to treat BPH3
The opportunities and barriers for developing tumour-infiltrating lymphocyte therapy for patients with advanced genitourinary cancers3
Generative AI in scientific publishing: disruptive or destructive?3
The potential role of the microbiota in prostate cancer pathogenesis and treatment3
Proteomic characterization of bladder cancer3
Bladder EpiCheck for NMIBC3
Author Correction: Advances in sliding clip renorrhaphy for partial nephrectomy3
Optimizing cystoscopy and TURBT: enhanced imaging and artificial intelligence3
Human sperm RNA in male infertility3
Control of oncogenic signalling in ccRCC3
From foes to friends: rethinking the role of lymph nodes in prostate cancer3
Understanding and integrating cytoreductive nephrectomy with immune checkpoint inhibitors in the management of metastatic RCC3
Knockout of extended pelvic lymph node dissection during radical cystectomy3
Health-related quality of life after curative treatment for muscle-invasive bladder cancer3
Urinary microbiota associated with OAB symptoms3
Promoting the health of men of all backgrounds: educating ourselves to build trust and improve care3
Should we screen for sleep apnoea in men with idiopathic infertility?3
Sex differences in bladder cancer: emerging data and call to action3
Metabolic alterations drive enzalutamide resistance3
Exercise, diet and psychological support for patients with testicular cancer3
Perspectives in primary hyperoxaluria — historical, current and future clinical interventions3
Mapping the human prostate at the cellular level3
Perspectives on chemsex3
Immunoliposome targeting IL-303
UPEC-mediated alteration of host mitochondrial function — a survival strategy2
20 years of ‘spilling the tea’ in urology2
NMIBC risk factors in patients treated with BCG2
Accessing information in the AI age2
Targeting TGCT2
Experimental in vitro, ex vivo and in vivo models in prostate cancer research2
Molecular and therapeutic landscape of non-clear cell renal carcinoma2
WGC in patients with localized prostate cancer2
PROTACs for prostate cancer2
Focusing on male infertility2
Effects of the environment on the evolution of the vertebrate urinary tract2
Abortion is a urology workforce issue2
Utility of PSA screening in transgender women receiving oestrogens2
Evolving the surgical approach for bladder cancer — robotic versus open radical cystectomy2
Supplementary selenium and vitamin E in non-muscle-invasive bladder cancer2
Body fluid-derived stem cells — an untapped stem cell source in genitourinary regeneration2
Metabolic flexibility in ccRCC2
The burden of kidney transplant evaluation — an older adults’ perspective2
The dynamic roles of the bladder tumour microenvironment2
Intravesical ICIs to reduce toxicity in NMIBC2
Intestinal microbiota drive CRPC2
Microplastics in the penis2
Islatravir implant as HIV-1 pre-exposure treatment2
Digital twins for personalized treatment in uro-oncology in the era of artificial intelligence2
AI for drug discovery2
Robotic kidney transplantation2
Patient-reported toxic effects of hypofractionated versus conventional RT2
Adjuvant personalized cancer vaccine: is this the end of metastatic kidney cancer2
The International Penile Prosthesis Implant Consensus Forum: clinical recommendations and surgical principles on the inflatable 3-piece penile prosthesis implant2
Embryonal origin of adult testicular macrophages1
Immunoproteasome inhibition in CRPC1
Author Correction: Metaverse in surgery — origins and future potential1
Paternal microbiome perturbations affect offspring outcomes1
Quality of life in sexual minorities following prostate cancer treatment1
Interactions between androgen and IGF1 axes in prostate tumorigenesis1
Reply to ‘The disruption of circadian rhythm as a potential mechanism of nocturia-like symptoms — a paediatric urology perspective’1
ML-guided decision for patient discharge location1
AI in prostate MRI: enhancing accuracy and reducing overdiagnosis1
Relationships between holmium laser enucleation of the prostate and prostate cancer1
Opening up about cancer and mental health1
First-morning urine samples to study the urobiome1
The yin and yang of chromosomal instability in prostate cancer1
What is fuelling the monkeypox outbreak?1
State of the art — biomarkers in advanced prostate cancer1
Urine biomarkers in bladder cancer — current status and future perspectives1
Therapeutic targeting of prostate-specific membrane antigen could limit its potential as benchmark imaging1
0.21614217758179